Bellevue Group Ag Incyte Corp Transaction History

Bellevue Group Ag

  • $4.67 Billion
  • Q3 2025

A detailed history of Bellevue Group Ag transactions in Incyte Corp stock. As of the latest transaction made, Bellevue Group Ag holds 1,440,686 shares of INCY stock, worth $150 Million. This represents 2.61% of its overall portfolio holdings.

Number of Shares
1,440,686
Previous 1,570,333 8.26%
Holding current value
$150 Million
Previous $107 Million 14.26%
% of portfolio
2.61%
Previous 2.43%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$67.27 - $86.96 $8.72 Million - $11.3 Million
-129,647 Reduced 8.26%
1,440,686 $122 Million
Q2 2025

Aug 14, 2025
SELL
$55.17 - $71.22 $28.8 Million - $37.1 Million
-521,447 Reduced 24.93%
1,570,333 $107 Million
Q1 2025

May 14, 2025
SELL
$60.0 - $75.26 $3.94 Million - $4.94 Million
-65,698 Reduced 3.05%
2,091,780 $127 Million
Q4 2024

Feb 14, 2025
BUY
$65.08 - $83.38 $450,809 - $577,573
6,927 Added 0.32%
2,157,478 $149 Million
Q3 2024

Nov 14, 2024
SELL
$57.33 - $68.61 $169,295 - $202,605
-2,953 Reduced 0.14%
2,150,551 $142 Million
Q2 2024

Aug 14, 2024
BUY
$51.18 - $63.75 $5,936 - $7,395
116 Added 0.01%
2,153,504 $131 Million
Q1 2024

May 15, 2024
SELL
$56.55 - $66.59 $188,368 - $221,811
-3,331 Reduced 0.15%
2,153,388 $123 Million
Q4 2023

Feb 14, 2024
SELL
$52.16 - $64.19 $17.5 Million - $21.5 Million
-334,731 Reduced 13.44%
2,156,719 $135 Million
Q3 2023

Nov 14, 2023
SELL
$57.77 - $65.93 $8.63 Million - $9.84 Million
-149,315 Reduced 5.65%
2,491,450 $144 Million
Q2 2023

Aug 14, 2023
SELL
$60.95 - $75.51 $12.2 Million - $15.1 Million
-199,735 Reduced 7.03%
2,640,765 $164 Million
Q1 2023

May 15, 2023
SELL
$70.23 - $86.01 $8.18 Million - $10 Million
-116,477 Reduced 3.94%
2,840,500 $205 Million
Q4 2022

Feb 14, 2023
BUY
$67.18 - $84.11 $14.3 Million - $17.9 Million
212,700 Added 7.75%
2,956,977 $238 Million
Q3 2022

Nov 14, 2022
SELL
$66.18 - $82.86 $1.93 Million - $2.41 Million
-29,100 Reduced 1.05%
2,744,277 $183 Million
Q2 2022

Aug 11, 2022
SELL
$66.18 - $83.18 $4.9 Million - $6.16 Million
-74,023 Reduced 2.6%
2,773,377 $211 Million
Q1 2022

May 13, 2022
SELL
$66.02 - $79.71 $7.24 Million - $8.74 Million
-109,600 Reduced 3.71%
2,847,400 $226 Million
Q3 2021

Nov 12, 2021
SELL
$68.67 - $84.02 $988,848 - $1.21 Million
-14,400 Reduced 0.48%
2,957,000 $203 Million
Q2 2021

Aug 12, 2021
SELL
$79.87 - $87.53 $2.74 Million - $3 Million
-34,300 Reduced 1.14%
2,971,400 $250 Million
Q1 2021

May 12, 2021
SELL
$76.02 - $100.5 $228,060 - $301,500
-3,000 Reduced 0.1%
3,005,700 $244 Million
Q4 2020

Feb 16, 2021
SELL
$80.74 - $97.7 $21.9 Million - $26.5 Million
-270,750 Reduced 8.26%
3,008,700 $262 Million
Q3 2020

Nov 16, 2020
SELL
$85.07 - $109.69 $1.12 Million - $1.44 Million
-13,150 Reduced 0.4%
3,279,450 $294 Million
Q2 2020

Aug 13, 2020
SELL
$74.18 - $108.93 $2.33 Million - $3.42 Million
-31,400 Reduced 0.94%
3,292,600 $342 Million
Q1 2020

May 14, 2020
SELL
$63.18 - $85.97 $12.2 Million - $16.6 Million
-193,000 Reduced 5.49%
3,324,000 $243 Million
Q4 2019

Feb 14, 2020
SELL
$73.04 - $95.72 $13.1 Million - $17.2 Million
-179,200 Reduced 4.85%
3,517,000 $307 Million
Q3 2019

Nov 14, 2019
SELL
$72.82 - $86.52 $105,588 - $125,454
-1,450 Reduced 0.04%
3,696,200 $274 Million
Q2 2019

Aug 14, 2019
BUY
$73.52 - $88.7 $268 Million - $324 Million
3,649,150 Added 7524.02%
3,697,650 $314 Million
Q1 2019

May 15, 2019
SELL
$63.56 - $88.17 $645,134 - $894,925
-10,150 Reduced 17.31%
48,500 $4.17 Million
Q4 2018

Feb 12, 2019
BUY
$58.5 - $69.94 $368,550 - $440,622
6,300 Added 12.03%
58,650 $3.73 Million
Q3 2018

Nov 13, 2018
SELL
$61.75 - $74.23 $154,375 - $185,575
-2,500 Reduced 4.56%
52,350 $3.62 Million
Q2 2018

Aug 07, 2018
SELL
$60.85 - $83.98 $10.7 Million - $14.8 Million
-175,776 Reduced 76.22%
54,850 $3.68 Million
Q1 2018

May 09, 2018
SELL
$83.06 - $100.98 $78,907 - $95,931
-950 Reduced 0.41%
230,626 $19.2 Million
Q4 2017

Feb 14, 2018
BUY
$93.56 - $116.6 $7.97 Million - $9.94 Million
85,210 Added 58.22%
231,576 $21.9 Million
Q3 2017

Nov 13, 2017
BUY
$109.15 - $138.27 $2.51 Million - $3.17 Million
22,954 Added 18.6%
146,366 $17.1 Million
Q2 2017

Aug 14, 2017
BUY
N/A
123,412
123,412 $15.5 Million

Others Institutions Holding INCY

# of Institutions
797
Shares Held
205M
Call Options Held
638K
Put Options Held
635K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $23.2B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email